370 related articles for article (PubMed ID: 28653397)
61. Acute Myeloid Leukemia: Biologic, Prognostic, and Therapeutic Insights.
Khaled S; Al Malki M; Marcucci G
Oncology (Williston Park); 2016 Apr; 30(4):318-29. PubMed ID: 27085330
[TBL] [Abstract][Full Text] [Related]
62. New strategies in acute myeloid leukemia: redefining prognostic markers to guide therapy.
Khan I; Altman JK; Licht JD
Clin Cancer Res; 2012 Oct; 18(19):5163-71. PubMed ID: 22893630
[TBL] [Abstract][Full Text] [Related]
63. [Genetic analysis and targeted therapy for acute myeloid leukemia].
Yamaguchi H
Rinsho Ketsueki; 2020; 61(4):350-357. PubMed ID: 32378580
[TBL] [Abstract][Full Text] [Related]
64. Molecular Landscape of Acute Myeloid Leukemia: Prognostic and Therapeutic Implications.
Marando L; Huntly BJP
Curr Oncol Rep; 2020 Jun; 22(6):61. PubMed ID: 32476069
[TBL] [Abstract][Full Text] [Related]
65. RAS mutations in acute myeloid leukaemia patients: A review and meta-analysis.
Liu X; Ye Q; Zhao XP; Zhang PB; Li S; Li RQ; Zhao XL
Clin Chim Acta; 2019 Feb; 489():254-260. PubMed ID: 30194935
[TBL] [Abstract][Full Text] [Related]
66. Coordinated alterations in RNA splicing and epigenetic regulation drive leukaemogenesis.
Yoshimi A; Lin KT; Wiseman DH; Rahman MA; Pastore A; Wang B; Lee SC; Micol JB; Zhang XJ; de Botton S; Penard-Lacronique V; Stein EM; Cho H; Miles RE; Inoue D; Albrecht TR; Somervaille TCP; Batta K; Amaral F; Simeoni F; Wilks DP; Cargo C; Intlekofer AM; Levine RL; Dvinge H; Bradley RK; Wagner EJ; Krainer AR; Abdel-Wahab O
Nature; 2019 Oct; 574(7777):273-277. PubMed ID: 31578525
[TBL] [Abstract][Full Text] [Related]
67. Targeting histone methyltransferase and demethylase in acute myeloid leukemia therapy.
Castelli G; Pelosi E; Testa U
Onco Targets Ther; 2018; 11():131-155. PubMed ID: 29343972
[TBL] [Abstract][Full Text] [Related]
68. Genomics of primary chemoresistance and remission induction failure in paediatric and adult acute myeloid leukaemia.
Brown FC; Cifani P; Drill E; He J; Still E; Zhong S; Balasubramanian S; Pavlick D; Yilmazel B; Knapp KM; Alonzo TA; Meshinchi S; Stone RM; Kornblau SM; Marcucci G; Gamis AS; Byrd JC; Gonen M; Levine RL; Kentsis A
Br J Haematol; 2017 Jan; 176(1):86-91. PubMed ID: 27766616
[TBL] [Abstract][Full Text] [Related]
69. [Novel therapies for acute myeloid leukemia based on genomic aberrations].
Umezawa Y; Kawamata N
Rinsho Ketsueki; 2019; 60(6):594-599. PubMed ID: 31281150
[TBL] [Abstract][Full Text] [Related]
70. Genetic hierarchy and temporal variegation in the clonal history of acute myeloid leukaemia.
Hirsch P; Zhang Y; Tang R; Joulin V; Boutroux H; Pronier E; Moatti H; Flandrin P; Marzac C; Bories D; Fava F; Mokrani H; Betems A; Lorre F; Favier R; Féger F; Mohty M; Douay L; Legrand O; Bilhou-Nabera C; Louache F; Delhommeau F
Nat Commun; 2016 Aug; 7():12475. PubMed ID: 27534895
[TBL] [Abstract][Full Text] [Related]
71. Landscape of Tumor Suppressor Mutations in Acute Myeloid Leukemia.
Panuzzo C; Signorino E; Calabrese C; Ali MS; Petiti J; Bracco E; Cilloni D
J Clin Med; 2020 Mar; 9(3):. PubMed ID: 32188030
[TBL] [Abstract][Full Text] [Related]
72. Genomic landscape in acute myeloid leukemia and its implications in risk classification and targeted therapies.
Hou HA; Tien HF
J Biomed Sci; 2020 Jul; 27(1):81. PubMed ID: 32690020
[TBL] [Abstract][Full Text] [Related]
73. Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemia.
Wouters BJ; Delwel R
Blood; 2016 Jan; 127(1):42-52. PubMed ID: 26660432
[TBL] [Abstract][Full Text] [Related]
74. Translating recent advances in the pathogenesis of acute myeloid leukemia to the clinic.
Bewersdorf JP; Abdel-Wahab O
Genes Dev; 2022 Mar; 36(5-6):259-277. PubMed ID: 35318270
[TBL] [Abstract][Full Text] [Related]
75. Insights into the molecular profiles of adult and paediatric acute myeloid leukaemia.
Aung MMK; Mills ML; Bittencourt-Silvestre J; Keeshan K
Mol Oncol; 2021 Sep; 15(9):2253-2272. PubMed ID: 33421304
[TBL] [Abstract][Full Text] [Related]
76. Genomic tools in acute myeloid leukemia: From the bench to the bedside.
White BS; DiPersio JF
Cancer; 2014 Apr; 120(8):1134-44. PubMed ID: 24474533
[TBL] [Abstract][Full Text] [Related]
77. Somatic Mutations Drive Specific, but Reversible, Epigenetic Heterogeneity States in AML.
Li S; Chen X; Wang J; Meydan C; Glass JL; Shih AH; Delwel R; Levine RL; Mason CE; Melnick AM
Cancer Discov; 2020 Dec; 10(12):1934-1949. PubMed ID: 32938585
[TBL] [Abstract][Full Text] [Related]
78. Emerging therapies for acute myeloid leukemia: translating biology into the clinic.
Kavanagh S; Murphy T; Law A; Yehudai D; Ho JM; Chan S; Schimmer AD
JCI Insight; 2017 Sep; 2(18):. PubMed ID: 28931762
[TBL] [Abstract][Full Text] [Related]
79. Clinical developments in epigenetic-directed therapies in acute myeloid leukemia.
Pan D; Rampal R; Mascarenhas J
Blood Adv; 2020 Mar; 4(5):970-982. PubMed ID: 32150613
[TBL] [Abstract][Full Text] [Related]
80. Genes and Mechanisms Responsible for Expansion of Acute Myeloid Leukaemia Blasts.
Dvořák M; Dvořáková M
Folia Biol (Praha); 2019; 65(1):11-23. PubMed ID: 31171078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
